Health & Healthcare

1998-2023 Serotype Data for Invasive Pneumococcal Disease Cases by Age Group from Active Bacterial Core surveillance

2013-2014 PHAP Associates by State

2020-2021 Nationwide Blood Donor Seroprevalence Survey Combined Infection- and Vaccination-Induced Seroprevalence Estimates

2020-2021 Nationwide Blood Donor Seroprevalence Survey Infection-Induced Seroprevalence Estimates

2020 Final Assisted Reproductive Technology (ART) Patient and Cycle Characteristics

2020 Final Assisted Reproductive Technology (ART) Services and Profiles

2020 Final Assisted Reproductive Technology (ART) Success Rates

2020 Final Assisted Reproductive Technology (ART) Summary

2021 Final Assisted Reproductive Technology (ART) Patient and Cycle Characteristics

2021 Final Assisted Reproductive Technology (ART) Services and Profiles

2021 Final Assisted Reproductive Technology (ART) Success Rates

2021 Final Assisted Reproductive Technology (ART) Summary

2022 Final Assisted Reproductive Technology (ART) Patient and Cycle Characteristics

2022 Final Assisted Reproductive Technology (ART) Services and Profiles

2022 Final Assisted Reproductive Technology (ART) Success Rates

2022 Final Assisted Reproductive Technology (ART) Summary

2022–2023 Nationwide Blood Donor Seroprevalence Survey Combined Infection- and Vaccination-Induced Seroprevalence Estimates

2023 Respiratory Virus Response - NSSP Emergency Department Visit Trajectories by State- COVID-19, Flu, RSV, Combined

500 Cities Census Tract-level Data (GIS Friendly Format), 2016 release

500 Cities Census Tract-level Data (GIS Friendly Format), 2017 release

500 Cities Census Tract-level Data (GIS Friendly Format), 2018 release

500 Cities Census Tract-level Data (GIS Friendly Format), 2019 release

500 Cities City-level Data (GIS Friendly Format), 2016 release

500 Cities City-level Data (GIS Friendly Format), 2017 release

500 Cities City-level Data (GIS Friendly Format), 2018 release

500 Cities City-level Data (GIS Friendly Format), 2019 release

500 Cities Local Data for Better Health, 2016 release

500 Cities Local Data for Better Health, 2017 release

500 Cities Local Data for Better Health, 2018 release

500 Cities Local Data for Better Health, 2019 release

A High-throughput, Turbulent-mixing, Condensation Aerosol Concentrator for Direct Aerosol Collection as a Liquid Suspension

Accountable Care Organization (ACO) Realizing Equity and Community Health (REACH) Eligible Beneficiaries

Accountable Care Organization Participants

Accountable Care Organizations

ACO Realizing Equity, Access and Community Health Aligned Beneficiaries

ACO Realizing Equity, Access and Community Health Financial and Quality Results

ACO Realizing Equity, Access and Community Health Providers

Active Bacterial Core surveillance (ABCs) Group A Streptococcus

Active Bacterial Core surveillance (ABCs) Group B Streptococcus

Active Bacterial Core surveillance (ABCs) Haemophilus influenzae

Active Bacterial Core surveillance (ABCs) Neisseria meningitidis

Active Bacterial Core surveillance (ABCs) Streptococcus pneumoniae

Adult Tobacco Consumption In The U.S., 2000-Present

Advance Investment Payment Spend Plan

Agency for Healthcare Research and Quality (AHRQ) Patient Safety Indicator 11 (PSI-11) Measure Rates

AGing, Independence, and Disability (AGID) Program Portal Data

Agreement of hip kinematics between two tracking marker configurations used with the 1 CODA pelvis during ergonomic roofing tasks

AH County of Occurrence COVID-19 Death Counts, 2020 Provisional

AH County of Residence COVID-19 Deaths Counts, 2020 Provisional

AH COVID-19 Death Counts by County and Week, 2020-present

AH Cumulative Provisional COVID-19 Death Counts by Place of Death and Age Group from 2/1/2020 to 7/18/2020

AH Cumulative Provisional COVID-19 Deaths by Sex, Race, and Age from 1/1/2020 to 7/28/2020

AH Cumulative Provisional Death Counts by Sex, Race, and Age from 1/1/2020 to 7/4/2020

AH Deaths by Educational Attainment, 2019-2020

AH Deaths by Week, Sex, and Age for 2018-2020

AH Deaths by Year, Sex, and Age for 2015-2020

AH Excess Deaths by Sex, Age, and Race and Hispanic Origin

AH Monthly COVID-19 Deaths, by Census Region, Age, Place, and Race and Hispanic Origin, 2020 Provisional

AH Monthly Provisional Counts of Deaths by Age Group and HHS region for Select Causes of Death, 2019-2021

AH Monthly Provisional Counts of Deaths for Select Causes of Death by Age, and Race and Hispanic Origin

AH Monthly Provisional Counts of Deaths for Select Causes of Death by Sex, Age, and Race and Hispanic Origin

AH Monthly Provisional COVID-19 Deaths, by Census Region, Age, and Race and Hispanic Origin

AH Provisional Cancer Death Counts by Month and Year, 2020-2021

AH Provisional COVID-19 Death Counts by Quarter and County

AH Provisional COVID-19 Death Counts by Week, Race, and Age, United States 2020-2023

AH Provisional COVID-19 Deaths and Contributing Conditions by Sex, Race and Hispanic Origin, and Age, 2020

AH Provisional COVID-19 Deaths by Age, United States, Week 40 2020 through Week 39 2021

AH Provisional COVID-19 Deaths by County and Age for 2020

AH Provisional COVID-19 Deaths by Educational Attainment, Race, Sex, and Age

AH Provisional COVID-19 Deaths by HHS Region, Race, Age 65plus

AH Provisional COVID-19 Deaths by HHS Region, Race, and Age, 2015-2021

AH Provisional COVID-19 Deaths by HHS Region, Race, and Age, 2015 to date

AH Provisional COVID-19 Deaths by HHS Region, Race, and Age Group, 2020-2021

AH Provisional COVID-19 Deaths by Hospital Referral Region

AH Provisional COVID-19 Deaths by Quarter, County and Age for 2020

AH Provisional COVID-19 Deaths By Race, Age, and Sex from 3/1/2020 to 7/31/2020

AH Provisional COVID-19 Deaths by Race and Educational Attainment

AH Provisional COVID-19 Deaths by Week and Age

AH Provisional COVID-19 Deaths by Week, Place of Death, and Age

AH Provisional COVID-19 Deaths by Week, Sex, and Race and Hispanic Origin

AH Provisional COVID-19 Deaths Counts by Health Service Area

AH Provisional Diabetes Death Counts for 2020

AH Quarterly Excess Deaths by State, Sex, Age, and Race

AH Sickle Cell Disease Provisional Death Counts 2019-2021

AIDS Drug Assistance Programs (ADAPS)

Air Quality Measures on the National Environmental Health Tracking Network

Alzheimer's Disease and Healthy Aging Data

American Communities Survey (ACS)

American Community Survey (ACS) - 2022-2023

American Community Survey (ACS) – Vision and Eye Health Surveillance

American Housing Survey (AHS)

American Rescue Plan (ARP) Rural Payments

An aggregated dataset of day 3 post-inoculation viral titer measurements from influenza A virus-infected ferret tissues

An aggregated dataset of serially collected influenza A virus morbidity and titer measurements from virus-infected ferrets.

An Investigation Into the Relationship Between Coal Workers’ Pneumoconiosis and Dust Exposure in U.S. Coal Miners

Anthropometric Database for the EMTs in the United States

Applied force alters sensorineural and peripheral vascular function in an animal model of hand-arm vibration syndrome

Applied pressure alters circulating hormone levels and biomarkers of peripheral vascular, sensorineural dysfunction

Archive COVID-19 LTC Program Vaccinations and Trends in the United States, Jurisdiction

Archive COVID-19 Vaccination and Case Trends by Age Group, United States

Archive COVID-19 Vaccination Demographic Trends by Report Date, National

Area Health Resource Files

ARPSP IQVIA Antibiotic Use

ASTDD Synopses of State Oral Health Programs - Selected indicators

Asthma Data

Asthma in children younger than age 18, by selected characteristics United States.

AtlasPlus

autism prevalence studies

BEAM Dashboard - Isolates by HHS Region

BEAM Dashboard - Report Data

BEAM Dashboard - Serotypes of concern Burden and Trajectory

BEAM Dashboard - Serotypes of concern Illnesses and Outbreaks

BEAM Dashboard – Top 30 Most Common Serotypes

Behavioral Risk Factor Surveillance System (BRFSS) - Mental Health Indicators

Behavioral Risk Factor Surveillance System (BRFSS) - Prevalence Data

Behavioral Risk Factor Surveillance System (BRFSS) Age-Adjusted Prevalence Data (2011 to present)

Behavioral Risk Factor Surveillance System (BRFSS) Historical Questions

Behavioral Risk Factor Surveillance System (BRFSS) Prevalence Data (2010 and prior)

Behavioral Risk Factors Selected Metropolitan Area Risk Trends (SMART) County Prevalence Data (2010 and prior)

Behavioral Risk Factors Selected Metropolitan Area Risk Trends (SMART) County Prevalence Data (2011 to 2012)

Behavioral Risk Factors Selected Metropolitan Area Risk Trends (SMART) MMSA Age-adjusted Prevalence Data (2011 to Present)

Behavioral Risk Factors Selected Metropolitan Area Risk Trends (SMART) MMSA Prevalence Data (2010 and Prior)

Behavioral Risk Factors Selected Metropolitan Area Risk Trends (SMART) MMSA Prevalence Data (2011 to Present)

Behavioral Risk Factors – Vision and Eye Health Surveillance

BHW Clincian Dashboards

BHW Program Applicant and Award Data

Biennial Overview of Post-acute and Long-term Care in the United States Data from the National Post-acute and Long-term Care Study

Biological effects of inhaled crude oil vapor. III. Pulmonary effects

Botulism

BRFSS Asthma Call-back Survey

BRFSS GIS Data and Documentation

BRFSS Prevalence And Trends Data Health Care Access/Coverage for 1995-2010

BRFSS Prevalence And Trends Data Health Care Access/Coverage for 2011

BRFSS Prevalence And Trends Data Tobacco Use - Adults Who Are Current Smokers for 1995-2010

BRFSS Prevalence and Trends Data Tobacco Use - Four Level Smoking Data for 1995-2010

BRFSS Prevalence and Trends Data Tobacco Use - Four Level Smoking Data for 2011

BRFSS Questionnaires & Statistical Briefs

BRFSS Vision Module Data – Vision & Eye Health

Cancer Research Citation Search

Cardiovascular Disease Death Rates, Trends, and Excess Death Rates Among US Adults (35+) by County and Age Group – 2010-2020

CDC Best Practices for Comprehensive Tobacco Control Programs - 2007

CDC Best Practices for Comprehensive Tobacco Control Programs - 2014

CDC BRFSS Annual Survey Data 1989-2023

CDC COVID-19 Cases and Deaths Ensemble Forecast Archive

CDC FTP Server

CDC GitHub organization repositories

CDC Internet Archive Data File Info

CDC Library Subscription Databases

CDC PRAMStat Data for 2000

CDC PRAMStat Data for 2001

CDC PRAMStat Data for 2002

CDC PRAMStat Data for 2003

CDC PRAMStat Data for 2004

CDC PRAMStat Data for 2005

CDC PRAMStat Data for 2006

CDC PRAMStat Data for 2007

CDC PRAMStat Data for 2008

CDC PRAMStat Data for 2009

CDC PRAMStat Data for 2010

CDC PRAMStat Data for 2011

CDC STATE System E-Cigarette Legislation - Licensure

CDC STATE System E-Cigarette Legislation - Preemption Summary

CDC STATE System E-Cigarette Legislation - Preemption

CDC STATE System E-Cigarette Legislation - Smokefree Campus

CDC STATE System E-Cigarette Legislation - Smokefree Indoor Air Summary

CDC STATE System E-Cigarette Legislation - Smokefree Indoor Air

CDC STATE System E-Cigarette Legislation - Tax

CDC STATE System E-Cigarette Legislation - Youth Access

CDC STATE System Tobacco Legislation - Licensure

CDC STATE System Tobacco Legislation - Preemption Summary

CDC STATE System Tobacco Legislation - Preemption

CDC STATE System Tobacco Legislation - Smokefree Campus

CDC STATE System Tobacco Legislation - Smokefree Indoor Air Summary

CDC STATE System Tobacco Legislation - Smokefree Indoor Air

CDC STATE System Tobacco Legislation - Tax

CDC STATE System Tobacco Legislation - Youth Access

CDC Summary Data - COVID-19 etc

CDC Text Corpora for Learners HTML Mirrors of MMWR, EID, and PCD

CDC Text Corpora for Learners MMWR, EID, and PCD Article Metadata

CDC Wastewater Data for Avian Influenza A (H5)

CDC Wastewater Data for Influenza A

CDC Wastewater Data for Mpox

CDC Wastewater Data for RSV

CDC Wastewater Data for SARS-CoV-2

CDC.gov CleanSlate and Relaunch URL Mappings

Census Bureau FTP Server

Centers for Disease Control and Prevention's (CDC) Abortion Surveillance System, 2009-2013

Centers for Medicare and Medicaid Services (CMS) Program Statistics

Centers for Medicare & Medicaid Services (CMS) Full API Download

Characteristics Associated with Successful Foodborne Outbreak Investigations, NEARS 2014 - 2016

Characterization of a multi-stage focusing nozzle for collection of spot samples for aerosol chemical analysis

Circular RNA hsa_circ_0008726 Targets the hsa-miR-206-3p/KLF4 Axis to Modulate 4,4’-Methylene Diphenyl Diisocyanate-Glutathione Conjugate-Induced Chemokine Transcription in Macrophages

Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration of the Uninsured

Climate Change and Human Health Literature (CCHHL) Portal

CMS Program Statistics - Medicare Advantage & Other Health Plan Enrollment

CMS Program Statistics - Medicare Newly Enrolled

Commercial Medical Insurance (MSCANCC) - Vision and Eye Health Surveillance

Community Resilience Estimates (CRE)

Community Resilience Estimates Equity Supplement

Community Water Fluoridation – State and County Level Statistics

Compact, High-flow, Water-based, Turbulent-mixing, Condensation Aerosol Concentrator for Collection of Spot Samples

Comparative Health Systems Performance (CHSP) Compendium of U.S. Health Systems

Comprehensive Care for Joint Replacement Model Metropolitan Statistical Areas

Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2023

Controlled Generation of Peracetic Acid Atmospheres for the Evaluation of Chemical Samplers

Correlation between graphitic carbon and elemental carbon in diesel particulate matter in workplace atmospheres-Dataset

Cost-to-Charge Ratio (CCR) Files

county-level ASD prevalence estimates

COVID-19-associated school closures, United States, February 18–June 30, 2020

COVID-19 Booster Dose Eligibility in the United States

COVID-19 Cases Among Healthcare Personnel, by week - ARCHIVED

COVID-19 Coverage Assistance Fund Claims Reimbursement to Health Care Providers and Facilities for Services to the Underinsured

COVID-19 Data Dashboard – Current Hospital Capacity Estimates – Snapshot

COVID-19 Deaths Among Healthcare Personnel, by week - ARCHIVED

COVID-19 Hospital Data from the National Hospital Care Survey

COVID-19 Primary Series Completion, Booster Dose Eligibility, and Booster Dose Receipt by Age, United States

COVID-19-related School Closures USA, 2020-2022

COVID-19 State, Tribal, Local, and Territorial Funding

COVID-19 Updated Vaccines Distributed

COVID-19 Vaccination Age and Sex Trends in the United States, National and Jurisdictional

COVID-19 Vaccination Demographics in the United States,National

COVID-19 Vaccination Trends in the United States,National and Jurisdictional

COVID-19 Vaccinations in the United States,County

COVID-19 Vaccinations in the United States,Jurisdiction

COVID-19 Vaccine Distribution Allocations by Jurisdiction - Janssen

COVID-19 Vaccine Distribution Allocations by Jurisdiction - Moderna

COVID-19 Vaccine Distribution Allocations by Jurisdiction - Pfizer

COVID-19 Vaccines Up to Date Status

COVID-19 Weekly Cases and Deaths by Age, Race/Ethnicity, and Sex - ARCHIVED

CPC Initiative - Participating Primary Care Practices

CPS Food Security Supplement Data

Cumulative Influenza Vaccination Coverage, Adults 18 years and older, by Age Group and Race/Ethnicity, United States

Cumulative Influenza Vaccination Coverage and Comparison, Adults 18 Years and Older, US, National Immunization Survey-Adult COVID Module

Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.

Cumulative Influenza Vaccination Coverage by Age Group, Race/Ethnicity, Urbanicity and Jurisdiction, NIS-ACM, Adults 18 Years and Older - NIS ACM

Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Pregnant Women 18-49 years

Cumulative Influenza Vaccination Coverage by Race/Ethnicity and Age Group, NIS-ACM (Archived)

Cumulative Influenza Vaccination Coverage by Race/Ethnicity and Age Group, NIS-ACM

Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States

Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to Date with the Updated 2023-24 COVID-19 Vaccine

Daily Census Tract-Level Ozone Concentrations, 2001-2005

Daily Census Tract-Level Ozone Concentrations, 2011-2014

Daily Census Tract-Level Ozone Concentrations, 2011-2015

Daily Census Tract-Level Ozone Concentrations, 2016 - 2020

Daily Census Tract-Level PM2.5 Concentrations, 2001-2005

Daily Census Tract-Level PM2.5 Concentrations, 2006-2010

Daily Census Tract-Level PM2.5 Concentrations, 2011-2014

Daily Census Tract-Level PM2.5 Concentrations, 2011-2015

Daily Census Tract-Level PM2.5 Concentrations, 2016 - 2020

Daily County-Level Ozone Concentrations, 2001-2019

Daily County-Level PM2.5 Concentrations, 2001-2014

Daily County-Level PM2.5 Concentrations, 2001-2019

DASH - Global School-based Student Health Survey (GSHS)

DASH - Youth Risk Behavior Surveillance System (YRBSS) High School - Excluding Sexual Identity

DASH - Youth Risk Behavior Surveillance System (YRBSS) High School – Including Sexual Orientation

DASH - Youth Risk Behavior Surveillance System (YRBSS) Middle School

DASH – School Health Profiles (Profiles)

Data and Maps for Eastern Equine Encephalitis

Data by Geography

Data Downloads Nursing Workforce Survey Data

dataset_for_databricks_demo

Death rates for suicide, by sex, race, Hispanic origin, and age United States

Deaths from Pneumonia and Influenza (P&I) and all deaths, by state and region, National Center For Health Statistics Mortality Surveillance System

Deaths in 122 U.S. cities - 1962-2016. 122 Cities Mortality Reporting System

Decennial Census of Population and Housing

Delay or nonreceipt of needed medical care, prescription drugs, or dental care during the past 12 months due to cost United States

Development of an Empirically Derived Measure of Food Safety Culture in Restaurants

dhds_dataset

Differences in Cumulative Influenza Vaccination Coverage by Selected Demographics, Adults 18 Year and Older, NIS Adult COVID Module

Disability and Health Data System (DHDS)

Distribution of COVID-19 Deaths and Populations, by Jurisdiction, Age, and Race and Hispanic Origin

Donor Registry Data

DQS Advanced Filters

DQS Cholesterol in adults age 20 and older, by selected characteristics United States

DQS Community hospital beds, by state United States

DQS Death rates for heart disease, by sex, race, Hispanic origin, and age United States from CDC WONDER

DQS Death rates for malignant neoplasms, by sex, race, Hispanic origin, and age United States

DQS Death rates for suicide, by sex, race, Hispanic origin, and age United States from CDC WONDER

DQS Delay or nonreceipt of needed medical care, prescription drugs, or dental care during the past 12 months due to cost United States(Archived)

DQS Dentists, by state United States.

DQS Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin United States from CDC WONDER

DQS Estimate of Emergency Department Visits in the United States, 2016-2022

DQS Fetal, late fetal, and perinatal mortality rates, by detailed race and Hispanic origin of mother United States

DQS Health care employment and wages, by selected occupations United States

DQS Hospital admission, average length of stay, outpatient visits, and outpatient surgery by type of ownership and size of hospital United States

DQS Hypertension in adults age 20 and older, by selected characteristics United States.

DQS Infant mortality rates, by race and Hispanic origin of mother, state, and territory United States and U.S. dependent areas (Archived)

DQS Infant, neonatal, and postneonatal mortality rates, by detailed race and Hispanic origin of mother United States

DQS Medicaid coverage among persons under age 65, by selected characteristics United States (Archived)

DQS National health spending United States

DQS National Post-Acute and Long-Term Care Users

DQS NHANES Footnotes

DQS NHANES Select Chronic Conditions Prevalence Estimates

DQS NHANES Select Infectious Diseases Prevalence Estimates

DQS NHANES Select Mean Dietary Intake Estimates

DQS NHANES Select Oral Health Prevalence Estimates

DQS NHIS Adult Summary Health Statistics

DQS NHIS Adult Summary Statistics Footnotes

DQS NHIS Child Summary Health Statistics

DQS NHIS Child Summary Statistics Footnotes

DQS NHIS Children Summary Statistics

DQS NHIS Functioning difficulties Footnotes

DQS NHIS Functioning difficulties in adults age 18 and older by selected characteristics United States

DQS Normal weight, overweight, and obesity among adults aged 20 and over, by selected characteristics United States

DQS NPALS Footnotes

DQS NVSS Footnotes

DQS NVSS Low birthweight live births, by state United States.

DQS Obesity among children and adolescents aged 2–19 years, by selected characteristics United States

DQS Personal healthcare spending United States

DQS Prescription drug use in the past 30 days, by sex, race and Hispanic origin, and age group United States

DQS Use of selected substances in the past 30 days among 12th graders, 10th graders, and 8th graders, by sex and race United States.

Drug Abuse Warning Network (DAWN)

Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin United States

Drug Use Data from Selected Hospitals

Early Model-based Provisional Estimates of Drug Overdose, Suicide, and Transportation-related Deaths

edav-demo-dataset-api

Effects of antimicrobial chemical exposures on influenza vaccination and antiviral immunity

Efficacy of Do-It-Yourself Air Filtration Units in Reducing Exposure to Simulated Respiratory Aerosols

Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021

Efficacy of universal masking for source control and personal protection from simulated respiratory aerosols in a room

Efforts to sustain education and subsidized meal programs during COVID-19-related school closures, United States, March-June 2020

Electronic Health Information Legal Epidemiology Data Set 2014

Environmental Antecedents of Foodborne Illness Outbreaks

Environmental Justice Index (EJI)

Estimates of Emergency Department Visits in the United States from 2016-2022

Examination of SARS-CoV-2 serological test results from multiple commercial and laboratory platforms with an in-house serum panel

Excess Deaths Associated with COVID-19

Firearm Mortality by State

FlyBase

Global Tobacco Surveillance System (GTSS) - Global Adult Tobacco Survey (GATS)

Global Tobacco Surveillance System (GTSS) - Global Health Professions Student Survey (GHPSS)

Global Tobacco Surveillance System (GTSS) - Global School Personnel Survey (GSPS)

Global Tobacco Surveillance System (GTSS) - Global Youth Tobacco Survey (GYTS)

HAICViz - Candidemia

HAICViz - CDI

HAICViz - iSA

HAICViz - MuGSI

hcp_influenza

HCUP Data Query Tools

HCUP Findings-At-A-Glance

HCUP Infographics

HCUP NEDS Database Documentation

HCUP NIS Database Documentation

HCUP NRD Database Documentation

HCUP Statistical Briefs

Health Center Patient Survey (HCPS)

Health Center Service Delivery and Look Alike Sites

Health conditions among children under age 18, by selected characteristics United States

Health conditions among male workers in mining and other industries reliant on manual labor occupations National Health Interview Survey, 2007–2018

Health Information National Trends Survey (HINTS)

Health Professions Training Programs

Healthcare Cost and Utilization Project Summary Tables

Healthy People 2020 Final Progress by Population Group Chart and Table

Healthy People 2020 Final Progress Table

Healthy People 2020 Foundation Health Measures

Healthy People 2020 Overview of Health Disparities

Healthy People 2020 Tobacco Use Objectives

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2015-2017

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2016-2018

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2017-2019

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2018-2020

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2019-2021

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County – 2021-2023

Heart Disease Mortality Data Among US Adults (35+) by State/Territory and County

HHS DRIVE

HHS Provider Relief Fund

HHS Unaccompanied Children Program

Home Health Agency Cost Report

Hospital Market Structure (HMS) Files

Household Pulse Survey - 2021-2024

Household Pulse Survey (HPS) COVID-19 Vaccination among People with Disabilities (muep-c3qd)

Household Pulse Survey (HPS) COVID-19 Vaccination among People with Disabilities (u4vw-xsmf)

HRSA Data Downloads Workforce Well-being Dashboard

HRSA Fact Sheets

HRSA Federal Tort Claims Act Search Tool

HRSA Grants

HRSA Shortage Areas

HRSA Uniform Data System

HUS_Footnote_Look_Up_ASTHCH

Impaired Driving Death Rate, by Age and Gender, 2012 & 2014, Region 8 - Denver

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, All States

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 1 - Boston

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 10 - Seattle

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 2 - New York

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 3 - Philadelphia

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 4 - Atlanta

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 5 - Chicago

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 6 - Dallas

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 7 - Kansas City

Impaired Driving Death Rate, by Age and Sex, 2012 & 2014, Region 9 - San Francisco

Indicators of Anxiety or Depression Based on Reported Frequency of Symptoms During Last 7 Days

Indicators of Health Insurance Coverage at the Time of Interview

Indicators of Reduced Access to Care Due to the Coronavirus Pandemic During Last 4 Weeks

Infant, neonatal, postneonatal, fetal, and perinatal mortality rates, by detailed race and Hispanic origin of mother United States

Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States

Influenza-related School Closures USA, 2011-2022

Influenza Vaccination Coverage for All Ages (6+ Months)

Inhalation of polycarbonate emissions generated during 3D printing processes affects neuroendocrine function in male rats

Innovation Center Data and Reports

Innovation Center Innovation Advisors

Innovation Center Milestones and Updates

Innovation Center Model Participants

Innovation Center Model Summary Information

Innovation Center Webinars and Forums

JMK_DHDS_POC

KID-Trend File

Lack of Social Connection

Long-term Care and COVID-19

Long-Term Care Facility Characteristics

Loss of Work Due to Illness from COVID-19

Lyme disease public use aggregated data with geography, 1992-2007

Lyme disease public use aggregated data with geography, 2008-2021

Lyme disease public use aggregated data with geography, 2022-2023

Lyme disease public use line-listed data without geography, 1992-2007

Lyme disease public use line-listed data without geography, 2008-2021

Lyme disease public use line-listed data without geography, 2022-2023

Mapping Injury, Overdose, and Violence - Census Tract

Mapping Injury, Overdose, and Violence - County

Mapping Injury, Overdose, and Violence - National

Mapping Injury, Overdose, and Violence - State

Market Saturation & Utilization Core-Based Statistical Areas

Market Saturation & Utilization State-County

Maternal and Child Health Bureau

Measles Case and Genetic Metadata, Operation Allies Welcome

Medicaid Claims (MAX) - Vision and Eye Health Surveillance

Medicaid coverage among persons under age 65, by selected characteristics United States

Medicaid Coverage Of Cessation Treatments And Barriers To Treatments

Medicaid Spending by Drug

Medical Expenditure Panel Survey (MEPS) Topics

Medicare COVID-19 Hospitalization Trends

Medicare Current Beneficiary Survey - Survey File

Medicare Current Beneficiary Survey (MCSB) - Cost Supplement

Medicare Dialysis Facilities

Medicare Durable Medical Equipment, Devices & Supplies - by Referring Provider

Medicare Fee for Service (FFS) claims (100%) – Vision and Eye Health Surveillance

Medicare Fee-For-Service Public Provider Enrollment

Medicare Monthly Enrollment

Medicare Part B Spending by Drug

Medicare Part D Prescribers - by Provider

Medicare Part D Spending by Drug

Medicare Physician & Other Practitioners - by Provider

Medicare Provider and Supplier Taxonomy Crosswalk

Medicare Telehealth Trends

Mental Health Care in the Last 4 Weeks

Mental Health Client-Level Data (MH-CLD)

MEPS Household Component

MEPS Topics Access to Health Care

MEPS Topics Children's Health

MEPS Topics Children's Insurance Coverage

MEPS Topics Dental Visits/Use/Events and Expenditures

MEPS Topics Disability

MEPS Topics Doctor Visits/Use/Events and Expenditures

MEPS Topics Doctors, Separately Billing

MEPS Topics Elderly Health Care

MEPS Topics Emergency Room Visits/Use/Events and Expenditures

MEPS Topics Employment Status

MEPS Topics Health Care Disparities

MEPS Topics Health Insurance Coverage

MEPS Topics Health Insurance Employer-sponsored

MEPS Topics Health Insurance Individually Purchased

MEPS Topics Health Status

MEPS Topics Home Health Care

MEPS Topics Injuries

MEPS Topics Jobs

MEPS Topics Medical Conditions

MEPS Topics Medical Providers Visits/Use/Events and Expenditures

MEPS Topics Medicare/Medicaid/SCHIP

MEPS Topics Men's Health

MEPS Topics Mental Health

MEPS Topics Methodological Research

MEPS Topics Minority Health

MEPS Topics Obesity

MEPS Topics Office-Based Visits/Use/Events and Expenditures

MEPS Topics Opioids

MEPS Topics Pharmacies

MEPS Topics Physicians, Separately Billing

MEPS Topics Prescription Drugs

MEPS Topics Preventive Care

MEPS Topics Priority Conditions -- Arthritis

MEPS Topics Priority Conditions -- Asthma

MEPS Topics Priority Conditions -- Cancer

MEPS Topics Priority Conditions -- Diabetes

MEPS Topics Priority Conditions -- Emphysema and Bronchitis

MEPS Topics Priority Conditions -- General

MEPS Topics Priority Conditions -- Heart Conditions

MEPS Topics Priority Conditions -- High Blood Pressure

MEPS Topics Priority Conditions -- High Cholesterol

MEPS Topics Priority Conditions -- Strokes

MEPS Topics Quality of Health Care

MEPS Topics Separately Billing Doctors

MEPS Topics State and Metro Area Estimates

MEPS Topics The Uninsured

MEPS Topics Usual Source of Care

MEPS Topics Veterans' Health

MEPS Topics Vision Impairment

MEPS Topics Women's Health

MicroRNA-Mediated Calcineurin Signaling Activation Induces CCL2, CCL3, CCL5, IL8 and Chemotactic Activities in 4,4’-Methylene Diphenyl Diisocyanate Exposed Macrophages

MicroRNA-Mediated Krüppel-Like Factor 4 upregulation Induces Alternatively Activated Macrophage-Associated Markers and Chemokines Transcription in 4,4'-Methylene Diphenyl Diisocyanate Exposed Macrophages

Military Health System (MHS) - Vision and Eye Health Surveillance System (VEHSS)

Monthly Counts of Deaths by Select Causes, 2014-2019

Monthly COVID-19 Death Rates per 100,000 Population by Age Group, Race and Ethnicity, Sex, and Region with Double Stratification

Monthly COVID-19 Death Rates per 100,000 Population by Age Group, Race and Ethnicity, Sex, and Region

Monthly Cumulative Number and Percent of Adults 60 Years and Older Who Received at least one RSV Vaccination Doses by Jurisdiction, United States

Monthly Cumulative Number and Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States

Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States

Monthly Cumulative Number and Percent of Children <8 Months Who Received Nirsevimab by Jurisdiction, United States

Monthly Cumulative Number and Percent of Persons Children 6 Months–17 Years Who Received ≥1 Influenza Vaccination Doses, by Influenza Season, Age Group, and Jurisdiction, United States

Monthly Cumulative Number and Percent of Persons Who Receive ≥1 Influenza Vaccination Doses and Comparison Between 2023-2024 and Two Previous Seasons, by Jurisdiction, United States

Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses and Comparison between 2024-25 and 2023-24 Seasons, by Age Group and Jurisdiction, United States

Monthly Cumulative Number and Percent of Persons Who Received 1+ 2024-25 COVID-19 Vaccination Doses, by Age Group, and Jurisdiction, United States

Monthly Cumulative Number and Percent of Persons Who Received ≥1 Influenza Vaccination Doses, by Flu Season, Age Group, and Jurisdiction

Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States (vugp-mqip)

Monthly Cumulative Number and Percent of Persons Who Received 1+ updated 2023-24 COVID-19 Vaccination Doses by Age Group and Jurisdiction, United States (wtw5-4wi3)

Monthly Cumulative Number and Percent of Who Received ≥1 Influenza Vaccination Doses and Comparison Between 2024-25 and Two Previous Seasons, by Jurisdiction, United States

Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant, United States

Monthly Provisional Counts of Deaths by Select Causes, 2020-2023

Monthly Rates of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System

Monthly Rates of Laboratory-Confirmed RSV Hospitalizations from the RSV-NET Surveillance System

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, All States

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, HHS Region 1 - Boston

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 10 - Seattle

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 2 - New York

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 3 - Philadelphia

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 4 - Atlanta

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 5 - Chicago

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 6 - Dallas

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 7 - Kansas City

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 8 - Denver

Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 9 - San Francisco

NAAG Tobacco Settlement Payments

National Adult Tobacco Survey (NATS)

National ART Surveillance System (NASS)

National Artesunate for Severe Malaria Program Artesunate Dosing Data- April to December 2019

National Artesunate for Severe Malaria Program Case Report Data- April to December 2019

National Artesunate for Severe Malaria Program Follow-On Antimalarial Dosing Data- April to December 2019

National Artesunate for Severe Malaria Program Microscopy Data- April to December 2019

National Community Based Survey of Supports for Healthy Eating and Active Living (CBS HEAL)

National Environmental Public Health Tracking Network

National Health and Aging Trends Study (NHATS) – Vision and Eye Health Surveillance System (VEHSS)

National Health and Nutrition Examination Survey (NHANES) – Vision and Eye Health Surveillance

National Health and Nutrition Examination Survey (NHANES)

National Health Interview Survey (NHIS) - Mental Health Indicators

National Health Interview Survey (NHIS) 2013-2023

National Health Interview Survey (NHIS) – Vision and Eye Health Surveillance

National Health Service Corps (NHSC), Nurse Corps, and Substance Use Disorder Treatment and Recovery (STAR) and other Programs

National Healthcare Quality and Disparities Reports

National Immunization Survey Adult COVID Module (NIS-ACM) RespVaxView| Data | Centers for Disease Control and Prevention (cdc.gov)

National Immunization Survey Adult COVID Module (NIS-ACM) Trends in Behavioral Indicators Among Unvaccinated People

National Immunization Survey Adult COVID Module (NIS-ACM) Trends in Vaccination Status and Intent

National Immunization Survey Adult COVID Module (NIS-ACM) Vaccination Status and Intent by Demographics

National Immunization Survey Child COVID Module (NIS-CCM) COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)-Archived

National Immunization Survey Child COVID Module (NIS-CCM) COVIDVaxViews| Data | Centers for Disease Control and Prevention (cdc.gov)

National Immunization Survey Child COVID Module (NIS-CCM) Vaccination Status and Intent by Demographics | Data | Centers for Disease Control and Prevention (cdc.gov)

National Immunization Survey (NIS)

National Mental Health Services Survey (N-MHSS)

National Respiratory and Enteric Virus Surveillance System (NREVSS) - RSV

National Substance Use and Mental Health Services Survey (N-SUMHSS)

National Survey of Children's Health (NSCH) - 2020-2023

National Survey of Children’s Health (NSCH) and National Survey of Children with Special Health Care Needs Chartbooks

National Survey of Children’s Health (NSCH) – Vision and Eye Health Surveillance

National Survey of Children's Health (NSCH)

National Survey of College Graduates - 2021 Data Tables

National Survey of College Graduates - 2021

National Survey of Drug Use and Health

National Survey of Family Growth (NSFG) - 2006-2023 (with some pre 2006)

National Survey of Older Americans Act Participants (NSOAAP)

National Survey of Organ Donation Attitudes and Practices

National Survey of Substance Abuse Treatment Services

National Survey on Drug Use and Health (NSDUH)

National Syndromic Surveillance Program (NSSP) Mental Health-Related Emergency Department Visit Rates

National Youth in Transition Database (NYTD)

National Youth Tobacco Survey - 1999-2000, 2002, 2004, 2006, 2009-2023

Nationwide Blood Donor Seroprevalence - 2020-2021

Nationwide Commercial Laboratory Seroprevalence Survey

NCHS - Age-adjusted Death Rates for Selected Major Causes of Death

NCHS - Birth Rates for Females by Age Group United States

NCHS - Birth Rates for Unmarried Women by Age, Race, and Hispanic Origin United States

NCHS - Birth Rates for Women Aged 15-17, 17-18, and 15-19 United States, 1960-2015

NCHS - Births and General Fertility Rates United States

NCHS - Births to Unmarried Women by Age Group United States

NCHS - Childhood Mortality Rates

NCHS - Death rates and life expectancy at birth

NCHS - Drug Poisoning Mortality by County United States (p56q-jrxg)

NCHS - Drug Poisoning Mortality by County United States (rpvx-m2md)

NCHS - Drug Poisoning Mortality by County United States

NCHS - Drug Poisoning Mortality by State United States (jx6g-fdh6)

NCHS - Drug Poisoning Mortality by State United States (xbxb-epbu)

NCHS - Drug Poisoning Mortality by State United States

NCHS - Infant and neonatal mortality rates United States, 1915-2013

NCHS - Infant Mortality Rates, by Race United States, 1915-2013

NCHS - Injury Mortality United States

NCHS - Leading Causes of Death United States

NCHS - Natality Measures for Females by Hispanic Origin Subgroup United States

NCHS - Natality Measures for Females by Race and Hispanic Origin United States

NCHS - Nonmarital Birth Rates, by Age Group for All Women Age 15-44 United States, 1970-2013

NCHS - Percent Distribution of Births for Females by Age Group United States

NCHS - Percent Distribution of Births to Unmarried Women by Age Group United States

NCHS - Potentially Excess Deaths from the Five Leading Causes of Death

NCHS - Pregnancy and Live Birth Rates, by Marital Status and Race and Hispanic Origin United States, 1990-2010

NCHS - Pregnancy Rates, by Age for Hispanic Women United States, 1990-2010

NCHS - Teen Birth Rates for Age Group 15-19 in the United States by County

NCHS - Teen Birth Rates for Females by Age Group, Race, and Hispanic Origin United States

NCHS - Top Five Leading Causes of Death United States, 1990, 1950, 2000

NCHS - U.S. and State Trends on Teen Births

NCHS - VSRR Quarterly provisional estimates for infant mortality

NCHS - VSRR Quarterly provisional estimates for selected birth indicators

NCHS - VSRR Quarterly provisional estimates for selected indicators of mortality

NCHS Rapid Surveys System

NCHS Synthetic Linked 2018 NHIS-HUD-CMS Data

ncird influenza a virus morbidity and titer measurements from ferrets/aggregated dataset of serially collected influenza a virus morbidity etc

New Chikungunya Cases Reported in the Americas

NHANES Select Chronic Conditions Prevalence Estimates

NHANES Select Infectious Diseases Prevalence Estimates

NHANES Select Mean Dietary Intake Estimates

NHANES Select Oral Health Prevalence Estimates

NHIS Adult 3-Year Summary Health Statistics

NHIS Adult Summary Health Statistics

NHIS Child Summary Health Statistics

NHIS Interactive Biannual Early Release Estimates

NHIS Interactive Quarterly Early Release Estimates

NHIS Teen

NIH RePorter

NIOSH Health Hazard Evaluation Program Noise Measurement Database

NIS 1993-2002 Discharge-Level Supplemental Files

NIS Hospital Ownership Files

NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease (5wdd-3g8t)

NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease (cz39-ahbn)

NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease (ju63-2fep)

NNDSS - TABLE 1A. Anthrax to Arboviral diseases, Eastern equine encephalitis virus disease (v2mh-3yzr)

NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis (52kh-2h7i)

NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis (mcdp-77g7)

NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis (q9sm-44y3)

NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis (vuhn-dxkt)

NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon to Powassan

NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease (pjtk-n43k)

NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease (vqyf-z2g3)

NNDSS - Table 1B. Arboviral diseases, Jamestown Canyon virus disease to Powassan virus disease (w46e-8kr3)

NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic (j6gu-p9yd)

NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic (kkix-nh4v)

NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic (tdge-ieq8)

NNDSS - TABLE 1BB. Q fever, Total to Q fever, Chronic (ygrm-jkkz)

NNDSS - Table 1C. Arboviral diseases, St. Louis encephalitis virus disease to West Nile virus disease (4ynm-6jgm)

NNDSS - Table 1C. Arboviral diseases, St. Louis encephalitis virus disease to West Nile virus disease (h4pd-hu6x)

NNDSS - Table 1C. Arboviral diseases, St. Louis encephalitis virus disease to West Nile virus disease

NNDSS - TABLE 1C. Arboviral diseases, St. Louis encephalitis virus to Western equine encephalitis virus

NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human (6kf3-4udg)

NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human (6uy5-4d9d)

NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human (9976-4iqj)

NNDSS - TABLE 1CC. Rabies, Animal to Rabies, Human (usyq-s7ip)

NNDSS - TABLE 1D. Arboviral diseases, West Nile virus to Babesiosis

NNDSS - Table 1D. Arboviral diseases, Western equine encephalitis virus disease to Babesiosis (3svv-v5nh)

NNDSS - Table 1D. Arboviral diseases, Western equine encephalitis virus disease to Babesiosis (hkr7-mcee)

NNDSS - Table 1D. Arboviral diseases, Western equine encephalitis virus disease to Babesiosis

NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome (2khz-k7sv)

NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome (iu3b-5ngj)

NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome (smic-9bf9)

NNDSS - TABLE 1DD. Rubella to Rubella, congenital syndrome (xssa-9qw5)

NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified) (4bft-6yws)

NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified) (b6sy-qq3u)

NNDSS - Table 1E. Botulism, Foodborne to Botulism, Other (wound & unspecified) (ngaa-n8ir)

NNDSS - TABLE 1E. Botulism, Foodborne to Botulism, Other

NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection) (2vtj-68zm)

NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection) (fuzh-wm4c)

NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection) (mvaf-qxac)

NNDSS - TABLE 1EE. Salmonella Paratyphi infection to Salmonellosis (excluding Salmonella Typhi infection and Salmonella Paratyphi infection) (rcdh-n3ej)

NNDSS - Table 1F. Brucellosis to Candida auris, clinical (9kbf-icdi)

NNDSS - Table 1F. Brucellosis to Candida auris, clinical (i43m-djm6)

NNDSS - TABLE 1F. Brucellosis to Candida auris, clinical (w54d-atna)

NNDSS - Table 1F. Brucellosis to Candida auris, clinical

NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis (cw4r-vcr3)

NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis (dkyk-v5f5)

NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis (mvsw-zuaf)

NNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis (x8jf-txib)

NNDSS - TABLE 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chancroid

NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection (cds4-6y7t)

NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection (h3kf-bqpq)

NNDSS - Table 1G. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae to Chlamydia trachomatis infection (hwyy-s2tt)

NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome (7rci-qmm9)

NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome (uw7a-a5t8)

NNDSS - TABLE 1GG. Smallpox to Streptococcal toxic shock syndrome

NNDSS - TABLE 1GG. Spotted fever rickettsiosis, Confirmed to Smallpox

NNDSS - Table 1H. Cholera to Coccidioidomycosis (68sm-zh95)

NNDSS - Table 1H. Cholera to Coccidioidomycosis (bqmb-vyka)

NNDSS - TABLE 1H. Cholera to Coccidioidomycosis (wycc-ffia)

NNDSS - Table 1H. Cholera to Coccidioidomycosis

NNDSS - TABLE 1HH. Streptococcal toxic shock syndrome to Syphilis, Primary and Secondary

NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary (6ie8-bpiy)

NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary (82nv-dn3y)

NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary

NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis (986w-8kut)

NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis (d4v7-r7ct)

NNDSS - TABLE 1I. Cryptosporidiosis to Cyclosporiasis (khjf-tq2k)

NNDSS - Table 1I. Cryptosporidiosis to Cyclosporiasis (n83i-w4cq)

NNDSS - TABLE 1II. Tetanus to Trichinellosis (6yz5-ufy2)

NNDSS - TABLE 1II. Tetanus to Trichinellosis (hyak-nxqs)

NNDSS - TABLE 1II. Tetanus to Trichinellosis (qbrk-85z2)

NNDSS - TABLE 1II. Tetanus to Trichinellosis

NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue (29js-qshz)

NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue (7jik-jwvu)

NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue (9axm-gjt8)

NNDSS - TABLE 1J. Dengue virus infections, Dengue to Severe dengue (nr42-fsyk)

NNDSS - TABLE 1JJ. Tuberculosis to Tularemia (rbrz-y4zd)

NNDSS - TABLE 1JJ. Tuberculosis to Tularemia (tfu6-pjxh)

NNDSS - TABLE 1JJ. Tuberculosis to Tularemia

NNDSS - TABLE 1JJ. Tularemia to Vancomycin-intermediate Staphylococcus aureus

NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection (9d9z-vf8f)

NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection (bqse-bujd)

NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection (gepg-djaz)

NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection (sixg-saap)

NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity (29xv-7ajw)

NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity (759d-qk63)

NNDSS - TABLE 1KK. Vancomycin-intermediate Staphylococcus aureus to Varicella morbidity

NNDSS - TABLE 1KK. Vancomycin-resistant Staphylococcus aureus to Varicella morbidity

NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis (8cyw-fici)

NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis (vzfn-ifh5)

NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis (wzwe-859x)

NNDSS - TABLE 1L. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Giardiasis

NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable (g3c9-wbme)

NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable (u92k-ms37)

NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable (vq7a-fvin)

NNDSS - TABLE 1LL. Vibriosis, Confirmed to Vibriosis, Probable

NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b (97bc-2r74)

NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b (dp9i-idru)

NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease, Age <5 years, Serotype b (u7e4-s8zi)

NNDSS - TABLE 1M. Gonorrhea to Haemophilus influenzae, invasive disease (age <5 years), Serotype b

NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Chapare virus to Ebola virus

NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus (a93x-tfzm)

NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus (ppmd-3u54)

NNDSS - TABLE 1MM. Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus to Guanarito virus

NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype to Unknown serotype (d2zt-4m8y)

NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype to Unknown serotype (ekcb-r85s)

NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype to Unknown serotype (g6fu-zp23)

NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, (age <5 years), Non-b serotype to Unknown serotype

NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Guanarito virus to Viral hemorrhagic fevers, Lassa virus

NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus (axsa-zcg5)

NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus (r8hr-3jkm)

NNDSS - TABLE 1NN. Viral hemorrhagic fevers, Junin virus to Viral hemorrhagic fevers, Lujo virus

NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome (a9xa-yrhn)

NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome (azpx-5hzx)

NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome (chmz-4uae)

NNDSS - TABLE 1O. Hansen's disease to Hantavirus pulmonary syndrome (tfcp-ufzp)

NNDSS - TABLE 1OO. Viral hemorrhagic fevers, Lujo virus to Viral hemorrhagic fevers, Marburg virus

NNDSS - TABLE 1OO. Viral hemorrhagic fevers, Machupo virus to Viral hemorrhagic fevers, Sabia virus

NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute (ex65-qa8z)

NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute (uu9i-eu7y)

NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute (w79a-dgrh)

NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis (viral, acute, by type), B

NNDSS - TABLE 1PP. Viral hemorrhagic fevers, Sabia virus to Zika virus disease, non-congenital

NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital (bk9t-cq4b)

NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital (qz67-9a9h)

NNDSS - TABLE 1PP. Yellow fever to Zika virus disease, non-congenital (rsk8-spa7)

NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable (fj6i-3v3k)

NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable (mwkk-wzmy)

NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C, acute, Probable

NNDSS - TABLE 1Q. Hepatitis B, perinatal infection to Hepatitis C (viral, acute), Probable

NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality (2qxe-cmv4)

NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality (ctu5-k6yz)

NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality (rnah-xd9n)

NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality (tv5g-74as)

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable (mrip-2k2a)

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable (r9mz-pvtk)

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable (rwap-xbst)

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable (xvdv-hq7x)

NNDSS - TABLE 1T. Invasive pneumococcal disease, age<5 , Confirmed to Invasive pneumococcal disease, age <5, Probable

NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis (5hvx-krph)

NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis (mr4u-abm2)

NNDSS - TABLE 1T. Invasive pneumococcal disease, Age<5 years, Confirmed to Legionellosis

NNDSS - TABLE 1U. Legionellosis to Listeriosis

NNDSS - TABLE 1U. Leptospirosis to Listeriosis, Probable (7gnu-j6js)

NNDSS - TABLE 1U. Leptospirosis to Listeriosis, Probable (aspp-bzzu)

NNDSS - TABLE 1U. Leptospirosis to Listeriosis, Probable (dwmy-m9r6)

NNDSS - TABLE 1V. Malaria to Measles, Imported

NNDSS - TABLE 1V. Malaria to Measles, Indigenous (7xhe-mv2e)

NNDSS - TABLE 1V. Malaria to Measles, Indigenous (9k8a-cbgx)

NNDSS - TABLE 1V. Malaria to Measles, Indigenous

NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B (4jje-6vv6)

NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B (bkwy-pyv3)

NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B (vmgc-uspy)

NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B

NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup (d7xj-2da2)

NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup (jr4g-zdpg)

NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup (m8jv-u92i)

NNDSS - TABLE 1X. Meningococcal disease, Other serogroups to Meningococcal disease, Unknown serogroup (wrrd-u9wx)

NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections (cjin-8pa3)

NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections (espg-acwi)

NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections (kxvg-q6s7)

NNDSS - TABLE 1Y. Mumps to Novel influenza A virus infections (q2dj-esu7)

NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic (247v-f7n9)

NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic (cqcc-kwwr)

NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic (kebt-3t25)

NNDSS - TABLE 1Z. Pertussis to Poliomyelitis, paralytic (u2nj-bus9)

NNDSS - Table I. infrequently reported notifiable diseases (45b4-9j7u)

NNDSS - Table I. infrequently reported notifiable diseases (5fyu-rtk3)

NNDSS - Table I. infrequently reported notifiable diseases (dwqk-w36f)

NNDSS - Table I. infrequently reported notifiable diseases (wcwi-x3uk)

NNDSS - Table I. infrequently reported notifiable diseases

NNDSS - Table II. Babesiosis to Campylobacteriosis (4y34-2pku)

NNDSS - Table II. Babesiosis to Campylobacteriosis (8n2k-mkiw)

NNDSS - Table II. Babesiosis to Campylobacteriosis (xuah-ug7z)

NNDSS - Table II. Babesiosis to Campylobacteriosis

NNDSS - Table II. Babesiosis to Coccidioidomycosis

NNDSS - Table II. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae

NNDSS - Table II. Chlamydia to Coccidioidomycosis (7mbm-jety)

NNDSS - Table II. Chlamydia to Coccidioidomycosis (97tt-n3j3)

NNDSS - Table II. Chlamydia to Coccidioidomycosis (n835-hpyp)

NNDSS - Table II. Chlamydia trachomatis infection to Coccidioidomycosis

NNDSS - Table II. Cryptosporidiosis to Dengue (9n3x-apcd)

NNDSS - Table II. Cryptosporidiosis to Dengue Hemorrhagic Fever

NNDSS - Table II. Cryptosporidiosis to Dengue (kikd-77zw)

NNDSS - Table II. Cryptosporidiosis to Dengue virus infection

NNDSS - Table II. Cryptosporidiosis to Dengue (yakh-mjxn)

NNDSS - Table II. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection

NNDSS - Table II. Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection to Undetermined

NNDSS - Table II. Ehrlichiosis and Anaplasmosis

NNDSS - Table II. Ehrlichiosis/Anaplasmosis

NNDSS - Table II. Giardiasis to Haemophilus influenza (9ix3-ryt6)

NNDSS - Table II. Giardiasis to Haemophilus influenza (afja-b25e)

NNDSS - Table II. Giardiasis to Haemophilus influenza (irpc-yf8f)

NNDSS - Table II. Giardiasis to Haemophilus influenza (m6gf-vfkz)

NNDSS - Table II. Giardiasis to Haemophilus influenza (mpdg-hf57)

NNDSS - Table II. Hepatitis (viral, acute) (65xe-6neq)

NNDSS - Table II. Hepatitis (viral, acute) (7vnz-2mjz)

NNDSS - Table II. Hepatitis (viral, acute) A & B

NNDSS - Table II. Hepatitis (viral, acute, by type) A & B

NNDSS - Table II. Hepatitis (viral, acute, by type) C

NNDSS - Table II. Hepatitis (viral, acute) C

NNDSS - Table II. Hepatitis (viral, acute) (rg4j-6mcc)

NNDSS - Table II. Invasive pneumococcal disease, age <5

NNDSS - Table II. Invasive pneumococcal disease, all ages

NNDSS - Table II. Invasive Pneumococcal Diseases, Age <5

NNDSS - Table II. Invasive Pneumococcal Diseases, All Ages

NNDSS - Table II. Invasive Pneumococcal to Legionellosis (23gt-ssfe)

NNDSS - Table II. Invasive Pneumococcal to Legionellosis (yqwx-bvu7)

NNDSS - Table II. Invasive Pneumococcal to Legionellosis

NNDSS - Table II. Legionellosis to Malaria (33kn-dpz2)

NNDSS - Table II. Legionellosis to Malaria (acdz-tk8j)

NNDSS - Table II. Lyme disease to Meningococcal (7pb7-w9us)

NNDSS - Table II. Lyme disease to Meningococcal (93k9-hy54)

NNDSS - Table II. Lyme disease to Meningococcal

NNDSS - Table II. Meningococcal disease to Pertussis

NNDSS - Table II. Meningococcal to Pertussis

NNDSS - Table II. Mumps to Rabies, animal (8rkx-vimh)

NNDSS - Table II. Mumps to Rabies, animal (bfe6-2gyq)

NNDSS - Table II. Mumps to Rabies, animal (d69q-iyrb)

NNDSS - Table II. Rabies, animal to Rubella, congenital syndrome

NNDSS - Table II. Rubella to Salmonellosis (4qb4-rsd8)

NNDSS - Table II. Rubella to Salmonellosis (d6kj-devz)

NNDSS - Table II. Salmonellosis (excluding typhoid fever and paratyphoid fever) to Shigellosis

NNDSS - Table II. Salmonellosis to Shigellosis

NNDSS - Table II. Shiga toxin to Shigellosis (n3wf-wtep)

NNDSS - Table II. Shiga toxin to Shigellosis (xv7k-8e7s)

NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis (6jgb-zrsp)

NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis (75b3-73qi)

NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis (ekd3-qu3w)

NNDSS - Table II. Spotted Fever Rickettsiosis to Syphilis (fqve-8wzt)

NNDSS - Table II. Spotted fever rickettsiosis to Syphilis, primary and secondary

NNDSS - Table II. Tetanus to Varicella (i42d-szcv)

NNDSS - Table II. Tetanus to Varicella (jz7r-jrma)

NNDSS - Table II. Tetanus to Vibriosis (nf22-99pv)

NNDSS - Table II. Tetanus to Vibriosis (tj26-bdgd)

NNDSS - Table II. Varicella to West Nile virus disease

NNDSS - Table II. Vibriosis

NNDSS - Table II. West Nile to Zika

NNDSS - Table II. West Nile virus disease (m5zs-rf6r)

NNDSS - Table II. West Nile virus disease (r7hc-32zu)

NNDSS - Table II. West Nile virus disease (sd5c-m3g5)

NNDSS - Table III. Tuberculosis

NNDSS - Table IV. Tuberculosis (ei7y-3g6s)

NNDSS - Table IV. Tuberculosis (pkas-xr96)

NNDSS - Table IV. Tuberculosis

NNDSS Weekly Data

NOHSS Adult Indicators - 2010 And Prior BRFSS

NOHSS Adult Indicators

NOHSS Child Indicators

Non-Medical Factor Measures for Census Tract, ACS 2017-2021

Non-Medical Factor Measures for County, ACS 2017-2021

Non-Medical Factor Measures for Place, ACS 2017-2021

Non-Medical Factor Measures for ZCTA, ACS 2017-2021

Normal weight, overweight, and obesity among adults aged 20 and over, by selected characteristics United States

NORS

North American Industry Classification System (NAICS)

Nowcast Predictions for Chikungunya Virus-Infected Travelers

Nowcast Predictions for Local Transmission of Chikungunya Virus

Number of Accountable Care Organization Assigned Beneficiaries by County

Number of Reported Malaria Cases by County— United States, 2016

Number of Reported Malaria Cases by County— United States, 2017

Nursing Home Affiliated Entity Performance Measures

Nutrition, Physical Activity, and Obesity - American Community Survey

Nutrition, Physical Activity, and Obesity - Behavioral Risk Factor Surveillance System

Nutrition, Physical Activity, and Obesity - National Immunization Survey (Breastfeeding)

Nutrition, Physical Activity, and Obesity - Policy and Environmental Data

Nutrition, Physical Activity, and Obesity - Women, Infant, and Child

Nutrition, Physical Activity, and Obesity - Youth Risk Behavior Surveillance System

NWSS Public SARS-CoV-2 Concentration in Wastewater Data

NWSS Public SARS-CoV-2 Wastewater Metric Data

Obesity among children and adolescents aged 2–19 years, by selected characteristics United States

Occupant and Alcohol-Impaired Driving Deaths in States, 2005-2014

Opioid Dispensing Rate Maps

Opioid Treatment Program Providers

Opt Out Affidavits

Organ Donation and Transplantation

Outbreak Data - Restaurant Grading

Outpatient Respiratory Illness Activity Map

Palmer Drought Severity Index, 1895-2016

Pathogen Detections Among Enrolled Children in the New Vaccine Surveillance Network (NVSN), Acute Respiratory Illnesses (ARI), 12 Month Rolling Period

Pathway to Practice (P2P) Resource Center

Patient Characteristics of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System

Payroll Based Journal Daily Non-Nurse Staffing

Pending Initial Logging and Tracking Non Physicians

Pending Initial Logging and Tracking Physicians

Peracetic acid effects on human bronchial cells in an air liquid interface

Percent Positivity of COVID-19 Nucleic Acid Amplification Tests by HHS Region, National Respiratory and Enteric Virus Surveillance System

Percent Positivity of Respiratory Syncytial Virus Nucleic Acid Amplification Tests by HHS Region, National Respiratory and Enteric Virus Surveillance System

Percent Positivity of Viral Detections Among Enrolled Children in the New Vaccine Surveillance Network (NVSN), Acute Respiratory Illnesses (ARI), 2017–Present

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 1 - Boston

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 10 - Seattle

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 2 - New York

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 3 - Philadelphia

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 4 - Atlanta

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 5 - Chicago

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 6 - Dallas

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 7 - Kansas City

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 8 - Denver

Percentage of Adults Who Report Driving After Drinking Too Much (in the past 30 days), 2012 & 2014, Region 9 - San Francisco

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, All States

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 1 - Boston

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 10 - Seattle

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 2 - New York

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 3 - Philadelphia

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 4 - Atlanta

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 5 - Chicago

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 6 - Dallas

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 7 - Kansas City

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 8 - Denver

Percentage of Drivers and Front Seat Passengers Wearing Seat Belts, 2012 & 2014, Region 9 - San Francisco

Percentage of Inpatient Beds Occupied by COVID-19 Patients – Change in 14 Day Period

Performance Year Financial and Quality Results

Persisting Cryptococcus Yeast Species Vishniacozyma victoriae and Cryptococcus neoformans Elicit Unique Airway Inflammation in Mice Following Repeated Exposure

Physician Experiences Related to COVID-19 from the National Ambulatory Medical Care Survey

PLACES and 500 Cities Data Dictionary

PLACES Census Tract Data (GIS Friendly Format), 2020 release

PLACES Census Tract Data (GIS Friendly Format), 2021 release

PLACES Census Tract Data (GIS Friendly Format), 2022 release

PLACES Census Tract Data (GIS Friendly Format), 2023 release

PLACES Census Tract Data (GIS Friendly Format), 2024 release

PLACES County Data (GIS Friendly Format), 2020 release

PLACES County Data (GIS Friendly Format), 2021 release

PLACES County Data (GIS Friendly Format), 2022 release

PLACES County Data (GIS Friendly Format), 2023 release

PLACES County Data (GIS Friendly Format), 2024 release

PLACES Local Data for Better Health, Census Tract Data 2020 release

PLACES Local Data for Better Health, Census Tract Data 2021 release

PLACES Local Data for Better Health, Census Tract Data 2022 release

PLACES Local Data for Better Health, Census Tract Data 2023 release

PLACES Local Data for Better Health, Census Tract Data 2024 release

PLACES Local Data for Better Health, County Data 2020 release

PLACES Local Data for Better Health, County Data 2021 release

PLACES Local Data for Better Health, County Data 2022 release

PLACES Local Data for Better Health, County Data 2023 release

PLACES Local Data for Better Health, County Data 2024 release

PLACES Local Data for Better Health, Place Data 2020 release

PLACES Local Data for Better Health, Place Data 2021 release

PLACES Local Data for Better Health, Place Data 2022 release

PLACES Local Data for Better Health, Place Data 2023 release

PLACES Local Data for Better Health, Place Data 2024 release

PLACES Local Data for Better Health, ZCTA Data 2020 release

PLACES Local Data for Better Health, ZCTA Data 2021 release

PLACES Local Data for Better Health, ZCTA Data 2022 release

PLACES Local Data for Better Health, ZCTA Data 2023 release

PLACES Local Data for Better Health, ZCTA Data 2024 release

PLACES Local Data for Better Health

PLACES Place Data (GIS Friendly Format), 2020 release

PLACES Place Data (GIS Friendly Format), 2021 release

PLACES Place Data (GIS Friendly Format), 2022 release

PLACES Place Data (GIS Friendly Format), 2023 release

PLACES Place Data (GIS Friendly Format), 2024 release

PLACES ZCTA Data (GIS Friendly Format), 2020 release

PLACES ZCTA Data (GIS Friendly Format), 2021 release

PLACES ZCTA Data (GIS Friendly Format), 2022 release

PLACES ZCTA Data (GIS Friendly Format), 2023 release

PLACES ZCTA Data (GIS Friendly Format), 2024 release

PONE-D-15-23803

Population Group Estimates used in the Healthy People 2020 Overview of Health Disparities

Population-Weighted Global Horizontal Irradiance, 1991-2012

Population-Weighted Ultraviolet Irradiance, 2004-2015

Post-COVID Conditions

Pregnancy Mortality Surveillance System (PRSS)

Pregnancy Risk Assessment Monitoring System (PRAMS) - 2000-2011

Pregnancy Risk Assessment Monitoring System (PRAMS) MCH Indicators 2016-2022

Preliminary 2024-2025 U.S. RSV Burden Estimates

Preliminary Estimates of Cumulative COVID-19-associated Hospitalizations by Week for 2024-2025

Preliminary Estimates of Cumulative RSV-associated Hospitalizations by Week for 2024-2025 season

Preliminary Estimates of Visits to Health Centers in the United States, January 2022-December 2024

Prevalence of Hearing Loss in the United States by Industry, 2000-2008

Prevalence of Pneumoconiosis and its Relationship to Dust Exposure in a Cohort of U.S. Bituminous Coal Miners and ex-Miners

Prevalence of Selected Measures Among Adults Aged 20 and Over United States, 1999-2000 through 2017-2018

Projectile Fluid Penetration and Flammability of Respirators and other Head/Facial Personal Protective Equipment (FPFPPE)

Prolonged Unplanned School Closures USA, 2011-2019

Provider of Services File - Clinical Laboratories

Provider of Services File - Internet Quality Improvement and Evaluation System - Home Health Agency, Ambulatory Surgical Center, and Hospice Providers

Provider Relief Fund & Accelerated and Advance Payments

Provider Relief Fund COVID-19 High-Impact Payments

Provider Relief Fund COVID-19 Nursing Home Quality Incentive Program

Provisional COVID-19 death counts and rates, by jurisdiction of residence and demographic characteristics

Provisional COVID-19 death counts and rates by month, jurisdiction of residence, and demographic characteristics

Provisional COVID-19 Death Counts by Age in Years, 2020-2023

Provisional COVID-19 Death Counts by Week Ending Date and State

Provisional COVID-19 Death Counts in the United States by County

Provisional COVID-19 death counts, rates, and percent of total deaths, by jurisdiction of residence

Provisional COVID-19 Deaths by County, and Race and Hispanic Origin

Provisional COVID-19 Deaths by HHS Region, Race, and Age

Provisional COVID-19 Deaths by Place of Death and Age

Provisional COVID-19 Deaths by Place of Death and State

Provisional COVID-19 Deaths by Race and Hispanic Origin, and Age

Provisional COVID-19 Deaths by Sex and Age

Provisional COVID-19 Deaths by Week and County Social Vulnerability Index

Provisional COVID-19 Deaths by Week and Urbanicity

Provisional COVID-19 Deaths by Week, Sex, and Age

Provisional COVID-19 Deaths Distribution of Deaths by Race and Hispanic Origin

Provisional COVID-19 Deaths Focus on Ages 0-18 Years

Provisional Death Counts for Coronavirus Disease (COVID-19)

Provisional Death Counts for Influenza, Pneumonia, and COVID-19

Provisional drug overdose death counts for specific drugs

Provisional Drug Overdose Deaths by Urban/Rural Classification Scheme for 12 month-ending December 2018-December 2020

Public Reporting of Missing Digital Contact Information

Public Use Microdata Sample (PUMS)

PubMed Central Open Datasets

Pulmonary evaluation of whole-body inhalation exposure of polycarbonate (PC) filament 3D printer emissions in rats

Question Inventory on Tobacco (QIT)

Rat-Tail Models for Studying Hand-Arm Vibration Syndrome A Comparison between Living and Cadaver Rat Tails

Rates and Trends in Heart Disease and Stroke Mortality Among US Adults (35+) by County, Age Group, Race/Ethnicity, and Sex – 2000-2019

Rates and Trends in Hypertension-related Cardiovascular Disease Mortality Among US Adults (35+) by County, Age Group, Race/Ethnicity, and Sex – 2000-2019

Rates of COVID-19 Cases or Deaths by Age Group and Updated (Bivalent) Booster Status

Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose

Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Second Booster Dose

Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status

Rates of Laboratory-Confirmed RSV, COVID-19, and Flu Hospitalizations from the RESP-NET Surveillance Systems

Rates of TBI-related Deaths by Age Group - United States, 2001 - 2010

Rates of TBI-related Emergency Department Visits, Hospitalizations, and Deaths - United States, 2001 – 2010

Rates of TBI-related Emergency Department Visits, Hospitalizations, and Deaths by Sex - United States, 2001 – 2010

Realizing Equity, Access, and Community Health ACOs

Reduced Access to Care During COVID-19

Release of Crystalline Silica Nanoparticles During Engineered Stone Fabrication

Resolution of Pulmonary Inflammation Induced by Carbon Nanotubes and Fullerenes in Mice Role of Macrophage Polarization

RESP-LENS

Respiratory Conditions Treated in the Emergency Department

Respiratory Syncytial Virus Laboratory Data (NREVSS)

Respiratory Virus Laboratory Emergency Department Network Surveillance (RESP-LENS)

Respiratory Virus Response (RVR) United States Hospitalization Metrics by Jurisdiction, Timeseries – ARCHIVED

Revalidation Clinic Group Practice Reassignment

Revalidation Due Date List

Revalidation Reassignment List

Rural Health Clinic All Owners

Ryan White HIV/AIDS Program

SAMHSA Synar Reports Youth Tobacco Sales

SARS-CoV-2 Variant Proportions

Science Clips

Selected Trend Table from Health, United States, 2011. Diabetes prevalence and glycemic control among adults 20 years of age and over, by sex, age, and race and Hispanic origin United States, selected years 1988 - 1994 through 2003 - 2006

Selected Trend Table from Health, United States, 2011. Health conditions among children under 18 years of age, by selected characteristics United States, average annual, selected years 1997 - 1999 through 2008 - 2010

Selected Trend Table from Health, United States, 2011. Leading causes of death and numbers of deaths, by sex, race, and Hispanic origin United States, 1980 and 2009

Selected Trend Table from Health, United States, 2011. Low birthweight live births, by race and Hispanic origin of mother, and state United States, 2000 - 2002, 2003 - 2005, and 2006 - 2008

Selected Trend Table from Health, United States, 2011. Vaccination coverage among children 19 - 35 months of age for selected diseases, by race, Hispanic origin, poverty level, and location of residence in metropolitan statistical area United States, sel

Skilled Nursing Facility All Owners

Skilled Nursing Facility Cost Report

Skilled Nursing Facility Enrollments

SMART BRFSS City and County Data and Documentation

Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) - Smoking-Attributable Expenditures (SAE)

Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) - Smoking-Attributable Mortality (SAM)

Social Determinants of Health (Beta Version) - Archived

Social Determinants of Health (SDOH)

Social Vulnerability Index (SVI)

SocrataDataRefresh_Test

Standardized Precipitation Evapotranspiration Index, 1895-2016

standardized precipitation evapotranspiration index (1895-2016)/cdc - ev data

Standardized Precipitation Index, 1895-2016

State-Level Restrictions on Vaccine Mandate – Currently in Effect

State-Level Restrictions on Vaccine Mandates – All

State-Level Vaccine Mandates - All

State-Level Vaccine Mandates - Currently in Effect

State Specific Influenza Vaccination Coverage Among Women With Live Birth- PRAMS, 2009-10 Influenza Season

State Tobacco Related Disparities Dashboard Data

Stroke Mortality Data Among US Adults (35+) by State/Territory and County – 2015-2017

Stroke Mortality Data Among US Adults (35+) by State/Territory and County – 2016-2018

Stroke Mortality Data Among US Adults (35+) by State/Territory and County – 2017-2019

Stroke Mortality Data Among US Adults (35+) by State/Territory and County – 2018-2020

Stroke Mortality Data Among US Adults (35+) by State/Territory and County – 2019-2021

Stroke Mortality Data Among US Adults (35+) by State/Territory and County – 2021-2023

Stroke Mortality Data Among US Adults (35+) by State/Territory and County

Supplemental Variables for Revisit Analyses

Survey Data - Restaurant Grading

Survey of Construction

Survey of Income and Program Participation (SIPP) - 2014, 2018-2023

TABLE III. Deaths in 122 U.S. cities (7esm-uptm)

TABLE III. Deaths in 122 U.S. cities (rpjd-ejph)

Telemedicine Use in the Last 4 Weeks

Tests for antibodies to trachoma PGP3 antigen

The effects of diesel exhaust inhalation on cardiovascular function

The ETS domain-containing hematopoietic transcription factor PU.1 mediates the induction of arachidonate 5-lipoxygenase by multi-walled carbon nanotubes in macrophages in vitro

The Tax Burden on Tobacco, 1970-2019

Total COVID-19 Deaths since January 1, 2020 by Age Group, Race/Ethnicity, and Sex

Total Inward Leakage (TIL) for Respiratory Protective Devices

Transplant Activity Report

Treatment Episode Data Set (TEDS)

Trend Weights for HCUP NIS Data

Trends in COVID-19 Cases and Deaths in the United States, by County-level Population Factors - ARCHIVED

Trends in Worker Hearing Loss by Industry Sector, 1981-2010

United States COVID-19 Community Levels by County

United States COVID-19 County Level Data Sources - ARCHIVED

United States COVID-19 County Level of Community Transmission as Originally Posted - ARCHIVED

United States COVID-19 County Level of Community Transmission Historical Changes - ARCHIVED

United States COVID-19 Hospitalization Metrics by Jurisdiction, Timeseries – ARCHIVED

United States Drought Monitor, 2000-2016

University of Illinois at Chicago Health Policy Center - Funding

US Census Annual Estimates of the Resident Population for Selected Age Groups by Sex for the United States

U.S. Chronic Disease Indicators

U.S. Life Expectancy at Birth by State and Census Tract - 2010-2015

U.S. President’s Emergency Plan For AIDS Relief (PEPFAR) - Data

U.S. President’s Emergency Plan For AIDS Relief (PEPFAR)

U.S. State and Territorial Gathering Bans March 11, 2020-August 15, 2021 by County by Day

U.S. State and Territorial Gathering Bans March 11, 2020-May 31, 2021 by County by Day

U.S. State and Territorial Orders Closing and Reopening Bars Issued from March 11, 2020 through August 15, 2021 by County by Day

U.S. State and Territorial Orders Closing and Reopening Bars Issued from March 11, 2020 through May 31, 2021 by County by Day

U.S. State and Territorial Orders Closing and Reopening Restaurants Issued from March 11, 2020 through August 15, 2021 by County by Day

U.S. State and Territorial Orders Closing and Reopening Restaurants Issued from March 11, 2020 through May 31, 2021 by County by Day

U.S. State and Territorial Public Mask Mandates From April 10, 2020 through August 15, 2021 by County by Day

U.S. State and Territorial Public Mask Mandates From April 10, 2020 through July 20, 2021 by County by Day

U.S. State and Territorial Public Mask Mandates From April 8, 2020 through August 15, 2021 by State by Day

U.S. State and Territorial Stay-At-Home Orders March 15, 2020 – August 15, 2021 by County by Day

U.S. State and Territorial Stay-At-Home Orders March 15, 2020 – May 31, 2021 by County by Day

U.S. State Life Expectancy by Sex, 2018

U.S. State Life Expectancy by Sex, 2019

U.S. State Life Expectancy by Sex, 2020

U.S. State Life Expectancy by Sex, 2021

U.S. State, Territorial, and County Stay-At-Home Orders March 15-May 5 by County by Day

USDA Reported H5N1 Bird Flu Detections in Poultry

Vaccination Concerns, Issues, and Motivators | RespVaxView | Data | Centers for Disease Control and Prevention (cdc.gov)

Vaccination Coverage among Adolescents (13-17 Years)

Vaccination Coverage among Adults (18+ Years)

Vaccination Coverage among Health Care Personnel

Vaccination Coverage among Nursing Home Residents

Vaccination Coverage among Pregnant Women

Vaccination Coverage among Young Children (0-35 Months)

Vaccination Coverage and Exemptions among Kindergartners

Vaccine Adverse Event Reporting System (VAERS) Data

Vaccine Hesitancy for COVID-19 County and local estimates

Vaccine Hesitancy for COVID-19 Public Use Microdata Areas (PUMAs)

Vaccines.gov COVID-19 vaccinating provider locations

Vaccines.gov Flu vaccinating provider locations

Value Modifier

VEHSS Medicare Fee for Service + Advantage (100%)

VEHSS Modeled Estimates

Vision Service Plan (VSP) – Vision and Eye Health Surveillance

Visits to physician offices, hospital outpatient departments, and hospital emergency departments, by age, sex, and race United States

VSRR - State and National Provisional Counts for Live Births, Deaths, and Infant Deaths

VSRR Provisional County-Level Drug Overdose Death Counts

VSRR Provisional Drug Overdose Death Counts

VSRR Provisional Maternal Death Counts and Rates

Water Fluoridation Data and Statistics

Water Fluoridation Statistics - Percent of PWS population receiving fluoridated water

Weekly Counts of Death by Jurisdiction and Select Causes of Death

Weekly Counts of Deaths by Jurisdiction and Age

Weekly Counts of Deaths by Jurisdiction, and Race and Hispanic Origin

Weekly Counts of Deaths by State and Select Causes, 2014-2019

Weekly counts of deaths from all causes by jurisdiction, 2015-2019

Weekly COVID-19 cases among persons ≥5 years old among unvaccinated and vaccinated with a BNT162b2 (Pfizer-BioNTech) primary series by age group — 22 U.S. jurisdictions, January 16 to May 28, 2022

Weekly COVID-19 County Level of Community Transmission Historical Changes - ARCHIVED

Weekly COVID-19 Vaccination Coverage Among Pregnant Women 18-49 Years, by Race and Ethnicity

Weekly COVID-19 Vaccination Coverage among Pregnant Women by Race and Ethnicity

Weekly Cumulative COVID-19 Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older

Weekly Cumulative COVID-19 Vaccination Coverage, by Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years

Weekly Cumulative Doses (in Millions) of Influenza Vaccine Distributed by Flu Season in the United States

Weekly Cumulative Doses (in Millions) of Influenza Vaccines Distributed by Season, United States

Weekly Cumulative Estimated Number of COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, by Season and Age Group, United States

Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, by Flu Season and Age Group, United States

Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States (ARCHIVED)

Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 60 years and older, United States

Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians’ Medical Offices, Adults 60 to 74 Years and 75 years and older, United States

Weekly Cumulative Estimated Number of Updated 2023-24 COVID-19 Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States, Data Source(s) IQVIA Pharmacy and Physician Medical Office Claims

Weekly Cumulative Influenza Vaccination Coverage, Adults 18 and Older, United States

Weekly Cumulative Influenza Vaccination Coverage and Comparison Between 2023–24 and 2024–25± by Jurisdiction, Children 6 Months–17 Years, United States

Weekly Cumulative Influenza Vaccination Coverage and Comparison Between 2024–25 and 2023–24, Overall, by Jurisdiction, Among Adults 18 Years and Older

Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States, Data Source Centers for Medicare & Medicaid Services Chronic Conditions Warehouse

Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States

Weekly Cumulative Influenza Vaccination Coverage by Flu Season, Selected Demographics, and Race and Ethnicity Among Children 6 Months-17 Years, United States

Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States (eudc-n39h)

Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States (vfj2-bfuw)

Weekly Cumulative Influenza Vaccination Coverage Comparison between Current and Previous Season, Children 6 Months through 17 Years, United States

Weekly Cumulative Influenza Vaccine Doses Distributed in the United States

Weekly Cumulative Percentage of Adults 18 Years and Older Vaccinated with the Updated 2023-24 COVID-19 Vaccine by Jurisdiction

Weekly Cumulative Percentage of Adults 60 Years and Older Vaccinated with Respiratory Syncytial Virus (RSV) Vaccine by Jurisdiction

Weekly Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to date with COVID-19 Vaccines and Comparison Between 2023-24 and 2024-25 by Jurisdiction

Weekly Cumulative Percentage of Children Ages 6 Months -17 Years Who Are Up to date with COVID-19 Vaccines by Selected Demographics and by Season, United States

Weekly Cumulative Percentage of Children Ages 6 Months -17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine, by Jurisdiction

Weekly Cumulative RSV Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated, United States

Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States, Data Source Centers for Medicare & Medicaid Services Chronic Conditions Warehouse

Weekly Cumulative RSV Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥75 years and enrolled in a Part D plan, United States, Data Source Centers for Medicare & Medicaid Services Chronic Conditions Warehouse

Weekly Cumulative Updated 2023-24 COVID-19 Vaccination Coverage, by Race and Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States, Data Source Centers for Medicare & Medicaid Services Chronic Conditions Warehouse

Weekly Differences in Cumulative COVID-19 Vaccination Coverage and Comparison Between 2024–25 and 2023–24 Among Adults 18 Years, Overall, by Selected Demographics

Weekly Differences in Cumulative COVID-19 Vaccination Coverage and Comparison Between 2024–25 and 2023–24, Overall, by Jurisdiction Among Adults 18 Years

Weekly Differences in Cumulative Influenza Vaccination Coverage and Comparison Between 2024-25 and 2023-24 Among Adults 18 Years, Overall, by Selected Demographics

Weekly Differences in Cumulative Influenza Vaccination Coverage by Selected Demographics and by Season, 2024-25 and 2024-25 Compared with 2023-24, Children 6 Months -17 Years, United States

Weekly Differences in Cumulative Percentage of Children Ages 6 Months -17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine, by Selected Demographics

Weekly Differences in Cumulative RSV Vaccination Coverage Among Adults 75 and Older and 60–74 Years with High-Risk Conditions Ever Vaccinated with RSV Vaccine, Overall, by Selected Demographics

Weekly Hospital Respiratory Data (HRD) Metrics by Jurisdiction, National Healthcare Safety Network (NHSN) (Preliminary)

Weekly Hospital Respiratory Data (HRD) Metrics by Jurisdiction, National Healthcare Safety Network (NHSN)

Weekly Influenza Vaccination Coverage Among Pregnant Women 18-49 Years, by Race and Ethnicity

Weekly Influenza Vaccination Coverage and Intent for Vaccination, Overall, by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older

Weekly Influenza Vaccination Status and Intent for Vaccination, Overall, by Selected Demographics, and Jurisdiction, Children 6 Months - 17 Years, 2023-24, United States

Weekly Influenza Vaccination Status and Intent for Vaccination, Overall, by Selected Demographics, and Jurisdiction, Children 6 Months-17 Years, United States

Weekly Parental Intent for Vaccination and Cumulative Percentage of Children 6 Months -17 Years Who are Up to date with the COVID-19 Vaccines by Season, United States

Weekly Parental Intent for Vaccination and Cumulative Percentage of Children 6 Months-17 Years who are up to date with the updated 2023-24 COVID-19 Vaccine

Weekly Provisional Counts of Deaths by State and Select Causes, 2020-2023

Weekly Rates of Laboratory-Confirmed COVID-19 Hospitalizations from the COVID-NET Surveillance System

Weekly Rates of Laboratory-Confirmed RSV Hospitalizations from the RSV-NET Surveillance System

Weekly Respiratory Syncytial Virus (RSV) Vaccination Coverage among Pregnant or Recently Pregnant Women 18-49 Years, by Race and Ethnicity

Weekly Respiratory Syncytial Virus (RSV) Vaccination Coverage among Pregnant Women by Race and Ethnicity

Weekly Respiratory Virus Vaccination Data, Children 6 Months-17 Years and Adults 18 Years and Older, National Immunization Survey

Weekly United States COVID-19 Cases and Deaths among Dialysis Patients - ARCHIVED

Weekly United States COVID-19 Cases and Deaths by County - ARCHIVED

Weekly United States COVID-19 Cases and Deaths by State - ARCHIVED

Weekly United States COVID-19 Hospitalization Metrics by County – ARCHIVED

Weekly United States COVID-19 Hospitalization Metrics by Jurisdiction – ARCHIVED

Weekly United States Hospitalization Metrics by Jurisdiction, During Mandatory Reporting Period from August 1, 2020 to April 30, 2024, and for Data Reported Voluntarily Beginning May 1, 2024, National Healthcare Safety Network (NHSN) - ARCHIVED

Weekly United States Hospitalization Metrics by Jurisdiction, During Mandatory Reporting Period from August 1, 2020 to April 30, 2024, and for Data Reported Voluntarily Beginning May 1, 2024, National Healthcare Safety Network (NHSN) (Historical)-ARCHIVED

Workforce Projections

Youth Risk Behavior Surveillance System (YRBSS) 2023-2025

Youth Risk Behavior Surveillance System (YRBSS)

Youth Risk Behavioral Surveillance System (YRBSS) - Mental Health Indicators

YRBS State Tobacco Variables 2013 - v2